4//SEC Filing
Nolan Lisa 4
Accession 0001140361-19-004276
CIK 0001228627other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:41 PM ET
Size
6.8 KB
Accession
0001140361-19-004276
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-02-28−1,625→ 3,250 total→ Common Stock (1,625 underlying) - Exercise/Conversion
Common Stock
2019-02-28+1,625→ 23,250 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]On January 20, 2017, the reporting person was granted 6,500 RSUs, of which 1,625 vested on February 28, 2018 and 1,625 vested on February 28, 2019. The remaining RSUs will vest in two equal annual installments on the last business day in February, beginning February 28, 2020.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001661400
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:41 PM ET
- Size
- 6.8 KB